News und Analysen
GenSight Biologics to Host Key Opinion Leader Webcast on Outcomes Among Compassionate Use Patients Treated Bilaterally with LUMEVOQ® in the US
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
Pulse Biosciences to Participate in the Stephens Annual Investment Conference
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced plans to
Granite REIT Declares Distribution for November 2021
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CAD $0.250 per stapled unit for the month of
CI Global Asset Management Funds and ETFs Win 13 Refinitiv Lipper Fund Awards
CI Global Asset Management (“CI GAM”) announced today that its investment funds have been recognized with 13 Refinitiv Canada Lipper Fund Awards for 2021. The awards recognize funds that have
Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”)
GenSight Biologics Reports Second Patient Case Showing Significant Visual Recovery after GS030 Optogenetic Treatment
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative
Pulse Biosciences Reports Third Quarter 2021 Financial Results
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced financial
GECI INTERNATIONAL : 2021-22 FIRST-HALF REVENUES
GECI International, the Digital and Technology specialist, is reporting stable first-half revenues, in line with its target to return to profitability.
FIRST-HALF KEY DEVELOPMENTS
The Group's
CI Global Asset Management Announces November 2021 Distributions for CI ETFs
CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending November 30, 2021 in respect of CI ETFs. In all cases, the distribution will be paid on
Mannatech Reports Third Quarter End 2021 Financial Results
Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2021.
GenSight Biologics to Present New Clinical Data of LUMEVOQ® and GS030 Gene Therapies at the American Academy of Ophthalmology 2021 Meeting
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
CI Financial Reports Record Financial Results for the Third Quarter of 2021
CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today released record financial results for the quarter ended September 30, 2021.
“It was another record financial quarter for CI and included a
CI Financial Reports Record Total Assets of $331.8 Billion for October 2021
CI Financial Corp. (“CI”) (TSX:CIX, NYSE:CIXX) today reported preliminary assets under management as at October 31, 2021 of $150.2 billion and wealth management assets of $181.6 billion, for total
CI Financial Makes Strategic Investment in GLASfunds, a Leading Alternative Investment Platform
CI Financial Corp. (“CI”) (TSX: CIX; NYSE: CIXX) announced today it has made a strategic investment in GLAS Funds, LLC (“GLASfunds™”), a turnkey alternative investment platform and alternative
CI Financial to Acquire Gofen and Glossberg, a US$7.5-Billion Chicago-Based RIA Serving High-Net-Worth Families
CI Financial Corp. (“CI”) (TSX:CIX; NYSE:CIXX) and Gofen and Glossberg, LLC (“Gofen”) today announced an agreement under which CI will acquire Gofen, a US$7.5-billion wealth and investment
Fuel Tech Reports 2021 Third Quarter Financial Results
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control, and water treatment in utility and
SunLike Series Natural Spectrum LEDs von Seoul Semiconductor von der Produktinnovationsmarke biOrb ausgewählt
Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), ein führender und weltweit tätiger Innovator im Bereich der LED-Technologie, gab bekannt, dass seine LEDs der SunLike-Serie mit natürlichem Spektrum
Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Selected by Product Innovation Brand biOrb
Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED technology, announced that its SunLike Series natural spectrum LEDs, which implement light that closely matches the
Granite Announces 2021 Third Quarter Results, $260 Million of New Acquisitions and Developments, and a 3.3% Distribution Increase Commencing December 2021
Granite Real Estate Investment Trust and Granite REIT Inc. (TSX: GRT.UN; NYSE: GRP.U) (“Granite” or the “Trust”) announced today its combined results for the three and nine month periods ended
Granite Announces the Establishment of a $250 Million At-the-Market Equity Program
Granite Real Estate Investment Trust and Granite REIT Inc. (TSX: GRT.UN; NYSE: GRP.U) (“Granite” or the “Trust”) announced today the establishment of a $250 million at-the-market equity
Pulse Biosciences Schedules Third Quarter 2021 Financial Results Conference Call for November 15, 2021
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, announced today it will report financial results for the third
CI Financial to Acquire R.H. Bluestein & Co., a $4.1-Billion Detroit and New York-Based RIA Focused on Ultra-High-Net-Worth and High-Net-Worth Families
CI Financial Corp. (“CI”) (TSX: CIX; NYSE: CIXX) and R.H. Bluestein & Co. (“Bluestein”) today announced an agreement under which CI will acquire a majority interest in Bluestein, a Birmingham
Gold – für viele Länder ein wichtiges Exportgut
Veris Health Showcased in PAVmed Digital Health Virtual Investor Event
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, hosted a virtual investor event with several
Azbil stellt Smart HART Modem Modell AZ-1SHM mit Stromversorgungsfunktion zur schnellen Lösung von Kommunikationsproblemen in Feldgeräten vor
Die Azbil Corporation (TOKYO:6845) hat die Markteinführung des Smart HART Modem Modells AZ-1SHM (im Folgenden „1SHM“) bekanntgegeben, das die Konfiguration und Einstellung von HART®*1-konformen